Loading company…
Riskpilot
← Back to search
Sign in
Get full access
Hisingen Vårdcentral AB
AB
Active
Org 5594664715
Lisa Sass Gata 1
General medical practice activities · NACE 8621
Est. 2024
1-4 employees
Watchlist
Share
Overview
Financials
People & ownership
Related companies
Revenue 2024
SEK 0
EBITDA margin
—
Equity ratio
1.2%
Financial strength
Net profit 2024
SEK 30K
EBITDA — year on year
SEK millions
0M
-0M
-1M
-1M
-1M
0M
2024
Key figures
Annual report 2024
Revenue
SEK 0
—
EBITDA
SEK -13K
—
Net profit
SEK 30K
—
Total assets
SEK 4,6M
—
Equity
SEK 55K
—
Employees
—
—
Company information
Legal name
Hisingen Vårdcentral AB
Org number
5594664715
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
4 januari 2024
Share capital
SEK 25 000
Employees
1-4
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamöterna
Company purpose
Vårdcentral som erbjuder primärvård, vilket innefattar läkarmottagning, akutmottagning, distriktssköterskemottagning, Astma-KOL mottagning, diabetesmottagning.
Contact
Address
Lisa Sass Gata 1
Email
hayder.al-kattan@lhkb.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in General medical practice activities
Companies in Göteborg
All Sweden companies
Revenue
SEK millions
0M
0M
1M
1M
1M
0M
2024
EBITDA
SEK millions
0M
0M
1M
1M
1M
0M
2024
Income statement
SEK thousands
Item
2024
Revenue
0
Staff expenses
—
EBITDA
−12
Depreciation & amort.
—
EBIT
−12
Net financials
63
Profit before tax
38
Tax
−8
Net profit
30
Balance sheet
SEK thousands
Item
2024
Total assets
4 586
Equity
55
Long-term debt
—
Short-term debt
4 518
Total debt
4 518
Financial ratios
5-year trend
EBITDA margin
-1250000.0%
This company
15.8%
Market median
-7911492% vs market
2024
2024
Equity ratio
1.2%
This company
38.2%
Market median
-97% vs market
2024
2024
Return on equity
54.8%
This company
18.4%
Market median
+198% vs market
2024
2024
Net profit margin
3032400.0%
This company
8.1%
Market median
+37436937% vs market
2024
2024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
2024
2024
Debt / equity
81.89×
This company
0.62×
Market median
-13108% vs market
2024
2024
Annual reports & filings
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-04 – 2024-12-31
View
PDF
Management
Actively employed in the business
Name
Role
Member since
Current (1)
DA
Doa Al-Kattan
Deputy Chief Executive Officer
Deputy Chief Executive Officer
2024
Board of directors
Non-executive oversight
Name
Role
Member since
Current (2)
HA
Hayder Al-Kattan
Chairman
2024
NA
Nara Al-Kattan
Deputy Board Member
2024
Shareholders
As of last annual report
Shareholder
Type
Ownership
Votes
Since
PEXEL Holding AB
Company
100%
100%
2025
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
PEXEL Holding AB
Hisingen Vårdcentral AB
(this company)
Board network connections
Board members of Hisingen Vårdcentral AB also hold positions in
0
other companies.
Person
Role here
Other companies
Doa Al-Kattan
Deputy Chief Executive Officer
0 companies
Hayder Al-Kattan
Chairman
0 companies
Nara Al-Kattan
Deputy Board Member
0 companies